Will GSK recover reputation through its ambitious products?

GSK, which has been frozen in performance, a company specializing in vaccines, has taken the first step for its revival.

The company recorded low performance in its ambitious products, such as the pneumococcus vaccine ‘Synflorix,’ and the cervical cancer vaccine ‘Cervarix,’ through competing against rivalry products.

Recently, however, the outline of its powerful developing vaccine pipeline h...